CoChat

COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee

Open access
Turner, Paul J., Ansotegui, Ignacio J., Campbell, Dianne E., Cardona, Victoria, Ebisawa, Motohiro, El-Gamal, Yehia, Fineman, Stanley, Geller, Mario, Gonzalez-Estrada, Alexei, Greenberger, Paul A., Leung, Agnes S.Y., Levin, Michael E., Muraro, Antonella, Sánchez Borges, Mario, Senna, Gianenrico, Tanno, Luciana K., Thong, Bernard Yu-Hor, Worm, Margitta · 2021 · World Allergy Organization Journal
Cited by 169

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Vaccines against COVID-19 (and its emerging variants) are an essential global intervention to control the current pandemic situation. Vaccines often cause adverse events; however, the vast majority of adverse events following immunization (AEFI) are a consequence of the vaccine stimulating a protective immune response, and not allergic in etiology. Anaphylaxis as an AEFI is uncommon, occurring at a rate of less than 1 per million doses for most vaccines. However, within the first days of initiating mass vaccination with the Pfizer-BioNTech COVID-19 vaccine BNT162b2, there were reports of anaphylaxis from the United Kingdom and United States. More recent data imply an incidence of anaphylaxis closer to 1:200,000 doses with respect to the Pfizer-BioNTech vaccine. In this position paper, we discuss the background to reactions to the current COVID-19 vaccines and relevant steps to mitigate against the risk of anaphylaxis as an AEFI. We propose a global surveillance strategy led by allergists in order to understand the potential risk and generate data to inform evidence-based guidance, and thus provide reassurance to public health bodies and members of the public.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.waojou.2021.100517

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Metadata

Authors
Turner, P. J., Ansotegui, I. J., Campbell, D. E., Cardona, V., Ebisawa, M., El-Gamal, Y., Fineman, S., Geller, M., Gonzalez-Estrada, A., Greenberger, P. A., Leung, A. S. Y., Levin, M. E., Muraro, A., Sánchez Borges, M., Senna, G., Tanno, L. K., Thong, B. Y.-H., & Worm, M.
Venue
World Allergy Organization Journal
Publisher
Elsevier BV
Published
2021-02
Volume
14
Issue
2
Pages
100517
ISSN
1939-4551 (ISSN-L)
OpenAlex
W3126621205
Cited by
169
References
4
FWCI
11.62
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee. https://app.cochat.ai/papers/10.1016/j.waojou.2021.100517
The paper
Turner, P. J., Ansotegui, I. J., Campbell, D. E., Cardona, V., Ebisawa, M., El-Gamal, Y., Fineman, S., Geller, M., Gonzalez-Estrada, A., Greenberger, P. A., Leung, A. S. Y., Levin, M. E., Muraro, A., Sánchez Borges, M., Senna, G., Tanno, L. K., Thong, B. Y.-H., & Worm, M. (2021). COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee. World Allergy Organization Journal. https://doi.org/10.1016/j.waojou.2021.100517

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.